Abstract
The need for contrast agents in MR imaging has been challenged over the past decade. The contrast obtained spontaneously between tissues does not appear sufficient for diagnosis or for the characterization of the nature and function of pathological processes. Today, small size molecules of gadolinium are widely used in a clinical setting and a large variety of contrasts can be obtained. New contrast agents are appearing with the goal of providing more specific information.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anzai Y, Blackwell KE, Hirschowitz SL et al. (1994) Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 192:709–715
Bonnemain B (1998) Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review. J Drug Target 6:167–174
Dousset V, Grossman R, Ramer K et al. (1992) Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 182:483–491
Dousset V, Delalande C, Ballarino L et al. (1999a) In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn Reson Med 41:329–333
Dousset V, Ballarino L, Delalande C et al. (1999b) Comparison of ultrasmall particles of iron oxide (USPIO) T2-weighted, conventional T2-weighted and gadolinium-enhanced Tlweighted MR images in rats with experimental autoimmune encephalomyelitis. AJNR Am J Neuroradiol 20:223–227
Forsén S, Hoffman RA (1963) Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance. J Chem Phys 39:2892–2901
Guimareas R, Clement O, Bittoun J et al. (1994) MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement. AJR Am J Roentgenol 162:201–207
Huot P, Dousset V, Hatier E et al. (1997) Improvement of postgadolinium contrast with magnetization transfer. Eur Radiol 7 (Suppl. 5):S174–S177
Harisinghani MG, Saini S, Weissleder R et al. (1999) MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. AJR Am J Roentgenol 172:1347–1351
Martin R, McFarland H (1995) Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 32:121–182
Mikawa M, Miwa T, Akaike T et al. (1999) An intelligent MRI contrast agent for tumor sensing. Proceedings of the International Society for Magnetic Resonance in Medicine, p 344
Rosen BR, Belliveau JW, Aronen HJ et al. (1991) Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 22:293–299
Ruehm SG, Quick HH, Corot C et al. (1999) MR imaging of atherosclerotic plaque with ultras mall super paramagnetic iron oxide (USPIO) in hyperlipidemic rabbits. Proceedings of the International Society for Magnetic Resonance in Medicine, p 81
Runge VM, Wells JW, Williams NM et al. (1995) Detectability of early brain meningitis with magnetic resonance imaging. Invest Radiol 30:484–495
Scott Enochs W, Harsh G, Hochberg F et al. (1999) Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. JMRI 9:228–232
Sorensen AG, Copen WA, Ostergaard L et al. (1999) Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 210:519–527
Taylor AM, Panting JR, Keegan J et al. (1999) Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography. JMRI 9:220–227
Weissleder R., Elizondo G., Wittenberg J. et al. (1990) Ultrasmall superparamagnetic iron oxide: characterization of a new class contrast agents for MR imaging. Radiology 175:494–498
Weissleder R, Cheng H-C, Bogdanova A et al. (1997) Magnetically labeled cells can be detected by MR imaging. JMRI 7:258–263
Wolff SD, Balaban RS (1989) Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 10:135–144
Zimmer C, Weissleder R, Poss K et al. (1995) MR imaging of phagocytosis in experimental gliomas. Radiology 197:533–538
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dousset, V. (2001). Recent Advances in MR Contrast Media. In: Demaerel, P. (eds) Recent Advances in Diagnostic Neuroradiology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56662-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-56662-2_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63003-3
Online ISBN: 978-3-642-56662-2
eBook Packages: Springer Book Archive